Want to see SLSN full AI Analyst Report?
SLSN Stock Chart & Stats
$0.94
$0.04(4.26%)
At close: 4:00 PM EDT
$0.94
$0.04(4.26%)
Day’s Range― - ―
52-Week Range$0.61 - $4.55
Previous CloseN/A
Volume5.30K
Average Volume (3M)50.43K
Market Cap
$66.07M
Enterprise Value$88.71
Total Cash (Recent Filing)$573.00K
Total Debt (Recent Filing)$22.28M
Price to Earnings (P/E)61.1
Beta1.74
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding70,632,450
10 Day Avg. Volume39,901
30 Day Avg. Volume50,427
Financial Highlights & Ratios
PEG Ratio-0.93
Price to Book (P/B)6.38
Price to Sales (P/S)1.81
P/FCF Ratio-10.51
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Gross Margin Recovery And Margin PlanThe margin improvement indicates early benefits from labor efficiency and reduced quality waste. If operational initiatives deliver the stated targets, higher gross profit and EBITDA margins could strengthen earnings resilience over the next several quarters.
Forward Order VisibilityA substantial shipped and open-order book provides demand visibility and supports production planning. Converting these orders into timely deliveries could underpin revenue recovery, improve capacity utilization, and reduce uncertainty around near-term commercial execution.
Proprietary Technology And Partner ExpansionNew proprietary technologies expand Solesence’s product capabilities into SPF hybrids and hair and scalp care, while partner activations support adoption. These developments can broaden applications and deepen customer relationships beyond existing products.
Bears Say
Persistently Weak Cash GenerationMinimal operating cash generation and negative free cash flow limit the company’s ability to fund investment, working capital, and obligations internally. Continued cash shortfalls could increase reliance on external funding and constrain strategic flexibility.
Revenue And Profitability DeteriorationThe combination of modest top-line contraction and sharply lower margins shows weakened operating momentum and reduced earnings resilience. Sustained pressure would make the company more vulnerable to shipment timing, input costs, and customer concentration.
Operational Execution And Leverage RiskProcess changes have already affected deliveries and quarterly results, creating execution risk while the transformation is implemented. Debt above equity also leaves less financial cushion if profitability remains weak or working-capital needs rise.
Solesence News
SLSN FAQ
What was Solesence’s price range in the past 12 months?
Solesence lowest stock price was $0.61 and its highest was $4.55 in the past 12 months.
What is Solesence’s market cap?
Solesence’s market cap is $66.07M.
When is Solesence’s upcoming earnings report date?
Solesence’s upcoming earnings report date is Nov 04, 2026 which is in 76 days.
How were Solesence’s earnings last quarter?
Currently, no data Available
Is Solesence overvalued?
According to Wall Street analysts Solesence’s price is currently Overvalued.
Does Solesence pay dividends?
Solesence does not currently pay dividends.
What is Solesence’s EPS estimate?
Solesence’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solesence have?
Solesence has 70,632,450 shares outstanding.
What happened to Solesence’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Solesence?
Currently, no hedge funds are holding shares in SLSN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Solesence Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
SLSN Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-16.17%
Trailing 12-Months
Company Description
Solesence
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
SLSN Company Deck
SLSN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive picture: near-term financial results were pressured by shipment delays and investments tied to the Transform and Transcend initiative (revenue down ~11%, net loss and negative adjusted EBITDA), but key positives include a 300-basis-point gross margin improvement to 26%, a $47M shipped + open orders book, new proprietary technology launches (Chromalum and WHSPR), completed co-marketing activations with brand partners, and a clear operational roadmap (SIOP, shift changes, facility consolidation) with reiterated guidance including a 30% gross profit floor and a plan to return to double-digit EBITDA margins by year-end. Given the balance of material execution risks and encouraging operational and commercial progress, the tone is cautiously optimistic but transitional.View all SLSN earnings summariesTechnical Analysis
Ownership Overview
5.91% Insiders
2.03% Mutual Funds
0.27% Other Institutional Investors
90.57% Public Companies and
Individual Investors